1. Home
  2. CBU vs LIVN Comparison

CBU vs LIVN Comparison

Compare CBU & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CBU

Community Bank System Inc.

HOLD

Current Price

$62.51

Market Cap

3.5B

Sector

Finance

ML Signal

HOLD

Logo LivaNova PLC

LIVN

LivaNova PLC

HOLD

Current Price

$63.70

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBU
LIVN
Founded
1866
1987
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.5B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
CBU
LIVN
Price
$62.51
$63.70
Analyst Decision
Hold
Buy
Analyst Count
4
7
Target Price
$66.67
$72.43
AVG Volume (30 Days)
228.5K
701.7K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
3.00%
N/A
EPS Growth
15.41
N/A
EPS
3.97
N/A
Revenue
$818,007,000.00
N/A
Revenue This Year
$13.46
$9.79
Revenue Next Year
$7.75
$6.89
P/E Ratio
$15.75
N/A
Revenue Growth
9.61
N/A
52 Week Low
$51.02
$34.00
52 Week High
$67.50
$71.58

Technical Indicators

Market Signals
Indicator
CBU
LIVN
Relative Strength Index (RSI) 68.10 49.80
Support Level $54.14 $61.60
Resistance Level $65.35 $65.25
Average True Range (ATR) 1.31 2.02
MACD 0.74 0.27
Stochastic Oscillator 94.83 51.02

Price Performance

Historical Comparison
CBU
LIVN

About CBU Community Bank System Inc.

Community Financial System Inc is a diversified financial services company providing a broad array of banking and other financial services to retail, commercial, institutional and governmental customers. The Company also offers comprehensive financial planning, trust administration and wealth management services through its Community Bank Wealth Management operating unit. It has four reportable operating business segments: Banking and Corporate, Employee Benefit Services, Insurance Services and Wealth Management Services.

About LIVN LivaNova PLC

UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Share on Social Networks: